Linnaeus

is a New Jersey-based biopharmaceutical company that researches and develops small-molecule novel therapeutics for the treatment of cancer...
Read more
Linnaeus CEO: Patrick T. Mooney

CEO

Patrick T. Mooney

CEO Approval Rating

90/100

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
1-25
Agree?
Funding
$27.5M

Linnaeus Competitors

1Prelude Therapeutics
2PIC Therapeutics
3Accent Therapeutics
4NexImmune
5Perthera
6Bolt
7Kinnate
8Shorla Pharma
9XinThera
10Novartis

Trending Companies